연구성과로 돌아가기

2020 연구자 정보 (343 / 997)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 교신저자 여부 Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Sameshima, Hiroki
(Sameshima, H)
Ono Pharmaceut Co Ltd, Med Oncol Med Affairs, Osaka, Japan

[JCR상위 17.6] A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data SCIE 17.6 GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY nboku@ncc.go.jp;
Satoh, Taroh
(Satoh, T)
제1저자 Osaka Univ, Grad Sch Med, Frontier Sci Canc & Chemotherapy, Suita, Osaka, Japan
Osaka Univ, Frontier Sci Canc & Chemotherapy, Grad Sch Med, Suita, Osaka, Japan
AAF-5193-2021
AAF-7913-2020
Satoh, Taroh

[JCR상위 17.6] Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer
[JCR상위 17.6] A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data
SCIE 17.6 GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY nboku@ncc.go.jp;
Shimizu, Takahiro
(Shimizu, T)
Vanderbilt Univ, Sch Med, Dept Surg, Nashville, TN 37212 USA
Vanderbilt Univ, Sch Med, Epithelial Biol Ctr, Med Ctr, MRB 4 10435F,2213 Garland Ave, Nashville, TN 37232 USA
Vanderbilt Univ, Sch Med, Cell & Dev Biol, Nashville, TN 37212 USA
Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto, Japan


[JCR상위 17.6] microRNA-30a arbitrates intestinal-type early gastric carcinogenesis by directly targeting ITGA2 SCIE 17.6 GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY eunyoung.choi@vumc.org;jim.goldenring@vumc.org;hkyang@snu.ac.kr;
Soe, May Thu
(Soe, MT)
Kyungpook Natl Univ, Dept Hort, Daegu, South Korea

[JCR상위 17.6] Overexpression of theRaphanus sativus RsMYB1using the flower-specific promoter (InMYB1) enhances anthocyanin accumulation in flowers of transgenic Petunia and their hybrids SCIE 17.6 AGRONOMY;GENETICS & HEREDITY;HORTICULTURE;PLANT SCIENCES ckkim@knu.ac.kr;
Sohn, Yoojin
(Sohn, Y)
Vanderbilt Univ, Sch Med, Epithelial Biol Ctr, Med Ctr, MRB 4 10435F,2213 Garland Ave, Nashville, TN 37232 USA
Vanderbilt Univ, Sch Med, Cell & Dev Biol, Nashville, TN 37212 USA
AAY-2375-2021
Sohn, Yoojin
0000-0002-1934-2073
Sohn, Yoojin
[JCR상위 17.6] microRNA-30a arbitrates intestinal-type early gastric carcinogenesis by directly targeting ITGA2 SCIE 17.6 GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY eunyoung.choi@vumc.org;jim.goldenring@vumc.org;hkyang@snu.ac.kr;
Suh, Yun-Suhk
(Suh, YS)
Seoul Natl Univ, Dept Surg, Coll Med, Seoul, South Korea

[JCR상위 17.6] microRNA-30a arbitrates intestinal-type early gastric carcinogenesis by directly targeting ITGA2 SCIE 17.6 GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY eunyoung.choi@vumc.org;jim.goldenring@vumc.org;hkyang@snu.ac.kr;
Tamura, Takao
(Tamura, T)
Kindai Univ, Fac Med, Dept Med Oncol, Osaka, Japan
Kindai Univ, Nara Hosp, Dept Med Oncol, Ikoma, Japan
Kindai Univ, Fac Med, Dept Med Oncol, Osakasayama, Japan
Kindai Univ, Dept Med Oncol, Nara Hosp, Ikoma, Japan


[JCR상위 17.6] Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer
[JCR상위 17.6] A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data
SCIE 17.6 GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY nboku@ncc.go.jp;
Tanimoto, Mitsunobu
(Tanimoto, M)
ONO Pharmaceut Co Ltd, Oncol Clin Dev Unit, Oncol Clin Dev Planning, Osaka, Japan

[JCR상위 17.6] Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer SCIE 17.6 GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY nboku@ncc.go.jp;
Tsuda, Masahiro
(Tsuda, M)
Hyogo Canc Ctr, Dept Gastroenterol Oncol, Akashi, Hyogo, Japan

[JCR상위 17.6] Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer
[JCR상위 17.6] A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data
SCIE 17.6 GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY nboku@ncc.go.jp;
Yang, Han-Kwang
(Yang, HK)
교신저자 Seoul Natl Univ, Coll Med, Canc Res Inst, 101 Daehak Ro, Seoul, South Korea
Seoul Natl Univ, Dept Surg, Coll Med, Seoul, South Korea
J-2767-2012
Yang, Han-Kwang

[JCR상위 17.6] microRNA-30a arbitrates intestinal-type early gastric carcinogenesis by directly targeting ITGA2 SCIE 17.6 GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY eunyoung.choi@vumc.org;jim.goldenring@vumc.org;hkyang@snu.ac.kr;
Yeh, Kun-Huei
(Yeh, KH)
Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan
Natl Taiwan Univ, Ctr Canc, Taipei, Taiwan
Natl Taiwan Univ, Canc Ctr, Taipei, Taiwan
Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Oncol, Coll Med, Taipei, Taiwan
HGD-3316-2022
Yeh, Kun-Huei
0000-0002-7306-174X
YEH, Kun-Huei
[JCR상위 17.6] Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer
[JCR상위 17.6] A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data
SCIE 17.6 GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY nboku@ncc.go.jp;
Yoshikawa, Takaki
(Yoshikawa, T)
Kanagawa Canc Ctr, Dept Gastrointestinal Surg, Yokohama, Kanagawa, Japan
Natl Canc Ctr, Dept Gastr Surg, Tokyo, Japan
Y-1580-2019
Yoshikawa, Takaki

[JCR상위 17.6] Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer
[JCR상위 17.6] A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data
SCIE 17.6 GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY nboku@ncc.go.jp;
Ahmed, Hafiz Furqan
(Ahmed, HF)
Khalifa Univ, Dept Elect Engn, Abu Dhabi, U Arab Emirates
Khalifa Univ, Dept Elect Engn & Comp Sci, Abu Dhabi 127788, U Arab Emirates
GWR-3787-2022
Ahmed, Hafiz
0000-0003-3762-2359
Ahmed, Hafiz Furqan
[JCR상위 17.8] A Family of Single-Stage High-Gain Dual-Buck Split-Source Inverters
[JCR상위 2.3] A Reliable Single-Phase Bipolar Buck-Boost Direct PWM AC-AC Converter With Continuous Input/Output Currents
SCIE 2.3 ENGINEERING, ELECTRICAL & ELECTRONIC
AUTOMATION & CONTROL SYSTEMS;ENGINEERING, ELECTRICAL & ELECTRONIC;INSTRUMENTS & INSTRUMENTATION
fazalakbar923@gmail.com;chahonny@knu.ac.kr;hafiz.ahmed@ku.ac.ae;khan.ashraf@ubc.ca;
hafiz.ahmed@ku.ac.ae;mohamed.elmoursi@ku.ac.ae;chahonny@knu.ac.kr;khalifa.halhosani@ku.ac.ae;bashar.zahawi@ku.ac.ae;
Akbar, Fazal
(Akbar, F)
제1저자 Kyungpook Natl Univ, Sch Energy Engn, Daegu 41566, South Korea AAU-7197-2020
akbar, fazal
0000-0002-2457-4506
Akbar, Fazal
[JCR상위 17.8] A Family of Single-Stage High-Gain Dual-Buck Split-Source Inverters
[JCR상위 11.2] Coupled-Inductor Buck-Boost Inverter With Reduced Current Ripple
SCIE 11.2 ENGINEERING, ELECTRICAL & ELECTRONIC fazalakbar923@gmail.com;chahonny@knu.ac.kr;hafiz.ahmed@ku.ac.ae;khan.ashraf@ubc.ca;
khan.ashraf@ubc.ca;wilson.eberle@ubc.ca;liwei.wang@ubc.ca;fazalakbar923@gmail.com;usman_705@ymail.com;waynelu.lu@gmail.com;magamy@albany.edu;
Bai, Changkyu
(Bai, C)
Pohang Univ Sci & Technol POSTECH, Dept Creat IT Engn, Pohang 37673, South Korea
0000-0001-8097-8866
Bai, Changkyu
[JCR상위 17.8] Control Strategy of Single-Phase Hybrid-Mode Cuk Inverter for LVRT Capability SCIE 17.8 ENGINEERING, ELECTRICAL & ELECTRONIC hbychol@knu.ac.kr;bck0325@postech.ac.kr;laijs@vt.edu;mkim@dongguk.edu;
페이지 이동: